Singer G - Search Results

1

Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer.

Chang HW, Lee SM, Goodman SN, Singer G, Cho SK, Sokoll LJ, Montz FJ, Roden R, Zhang Z, Chan DW, Kurman RJ, Shih IeM. Chang HW, et al. Among authors: singer g. J Natl Cancer Inst. 2002 Nov 20;94(22):1697-703. doi: 10.1093/jnci/94.22.1697. J Natl Cancer Inst. 2002. PMID: 12441325

2

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.

Singer G, Oldt R 3rd, Cohen Y, Wang BG, Sidransky D, Kurman RJ, Shih IeM. Singer G, et al. J Natl Cancer Inst. 2003 Mar 19;95(6):484-6. doi: 10.1093/jnci/95.6.484. J Natl Cancer Inst. 2003. PMID: 12644542

3

Diverse tumorigenic pathways in ovarian serous carcinoma.

Singer G, Kurman RJ, Chang HW, Cho SK, Shih IeM. Singer G, et al. Am J Pathol. 2002 Apr;160(4):1223-8. doi: 10.1016/s0002-9440(10)62549-7. Am J Pathol. 2002. PMID: 11943707 Free PMC article.

4

HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis.

Singer G, Kurman RJ, McMaster MT, Shih IeM. Singer G, et al. Am J Surg Pathol. 2002 Jul;26(7):914-20. doi: 10.1097/00000478-200207000-00010. Am J Surg Pathol. 2002. PMID: 12131159

5

Genotype analysis using human hair shaft.

Chang HW, Yen CY, Liu SY, Singer G, Shih IeM. Chang HW, et al. Among authors: singer g. Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):925-9. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12223440

6

Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor).

Singer G, Shih IeM, Truskinovsky A, Umudum H, Kurman RJ. Singer G, et al. Int J Gynecol Pathol. 2003 Jan;22(1):37-41. doi: 10.1097/00004347-200301000-00009. Int J Gynecol Pathol. 2003. PMID: 12496696

7

HLA-G is a potential tumor marker in malignant ascites.

Singer G, Rebmann V, Chen YC, Liu HT, Ali SZ, Reinsberg J, McMaster MT, Pfeiffer K, Chan DW, Wardelmann E, Grosse-Wilde H, Cheng CC, Kurman RJ, Shih IeM. Singer G, et al. Clin Cancer Res. 2003 Oct 1;9(12):4460-4. Clin Cancer Res. 2003. PMID: 14555519

8

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.

Singer G, Stöhr R, Cope L, Dehari R, Hartmann A, Cao DF, Wang TL, Kurman RJ, Shih IeM. Singer G, et al. Am J Surg Pathol. 2005 Feb;29(2):218-24. doi: 10.1097/01.pas.0000146025.91953.8d. Am J Surg Pathol. 2005. PMID: 15644779

9

Different types of microsatellite instability in ovarian carcinoma.

Singer G, Kallinowski T, Hartmann A, Dietmaier W, Wild PJ, Schraml P, Sauter G, Mihatsch MJ, Moch H. Singer G, et al. Int J Cancer. 2004 Nov 20;112(4):643-6. doi: 10.1002/ijc.20455. Int J Cancer. 2004. PMID: 15382045

10

The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.

Cohen Y, Singer G, Lavie O, Dong SM, Beller U, Sidransky D. Cohen Y, et al. Among authors: singer g. Clin Cancer Res. 2003 Aug 1;9(8):2981-4. Clin Cancer Res. 2003. PMID: 12912945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

675 results

Search Page

Filters